Silica nanoparticle-based dual imaging colloidal hybrids: cancer cell imaging and biodistribution
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Haisung | - |
dc.contributor.author | Sung, Dongkyung | - |
dc.contributor.author | Kim, Jinhoon | - |
dc.contributor.author | Kim, Byung-Tae | - |
dc.contributor.author | Wang, Tuntun | - |
dc.contributor.author | An, Seong Soo A. | - |
dc.contributor.author | Seo, Soo-Won | - |
dc.contributor.author | Yi, Dong Kee | - |
dc.date.available | 2020-02-28T14:44:52Z | - |
dc.date.created | 2020-02-06 | - |
dc.date.issued | 2015 | - |
dc.identifier.issn | 1178-2013 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/11868 | - |
dc.description.abstract | In this study, fluorescent dye-conjugated magnetic resonance (MR) imaging agents were investigated in T mode. Gadolinium-conjugated silica nanoparticles were successfully synthesized for both MR imaging and fluorescence diagnostics. Polyamine and polycarboxyl functional groups were modified chemically on the surface of the silica nanoparticles for efficient conjugation of gadolinium ions. The derived gadolinium-conjugated silica nanoparticles were investigated by zeta potential analysis, transmission electron microscopy, inductively coupled plasma mass spectrometry, and energy dispersive x-ray spectroscopy. MR equipment was used to investigate their use as contrast-enhancing agents in T-1 mode under a 9.4 T magnetic field. In addition, we tracked the distribution of the gadolinium-conjugated nanoparticles in both lung cancer cells and organs in mice. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | DOVE MEDICAL PRESS LTD | - |
dc.relation.isPartOf | INTERNATIONAL JOURNAL OF NANOMEDICINE | - |
dc.subject | IRON-OXIDE PARTICLES | - |
dc.subject | CONTRAST-MEDIUM | - |
dc.subject | AGENTS | - |
dc.subject | MRI | - |
dc.subject | DELIVERY | - |
dc.subject | GD | - |
dc.subject | ENHANCEMENT | - |
dc.subject | RELAXIVITY | - |
dc.subject | FILMS | - |
dc.title | Silica nanoparticle-based dual imaging colloidal hybrids: cancer cell imaging and biodistribution | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000365122300022 | - |
dc.identifier.doi | 10.2147/IJN.S88311 | - |
dc.identifier.bibliographicCitation | INTERNATIONAL JOURNAL OF NANOMEDICINE, v.10, pp.215 - + | - |
dc.identifier.scopusid | 2-s2.0-84947441680 | - |
dc.citation.endPage | + | - |
dc.citation.startPage | 215 | - |
dc.citation.title | INTERNATIONAL JOURNAL OF NANOMEDICINE | - |
dc.citation.volume | 10 | - |
dc.contributor.affiliatedAuthor | An, Seong Soo A. | - |
dc.type.docType | Article | - |
dc.subject.keywordAuthor | dual bioimaging | - |
dc.subject.keywordAuthor | MR imaging | - |
dc.subject.keywordAuthor | silica colloid | - |
dc.subject.keywordAuthor | T1 contrast imaging | - |
dc.subject.keywordAuthor | nanohybrid | - |
dc.subject.keywordPlus | IRON-OXIDE PARTICLES | - |
dc.subject.keywordPlus | CONTRAST-MEDIUM | - |
dc.subject.keywordPlus | AGENTS | - |
dc.subject.keywordPlus | MRI | - |
dc.subject.keywordPlus | DELIVERY | - |
dc.subject.keywordPlus | GD | - |
dc.subject.keywordPlus | ENHANCEMENT | - |
dc.subject.keywordPlus | RELAXIVITY | - |
dc.subject.keywordPlus | FILMS | - |
dc.relation.journalResearchArea | Science & Technology - Other Topics | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Nanoscience & Nanotechnology | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.